Home/Filings/4/0001209191-22-043510
4//SEC Filing

TOMBESI PAOLO 4

Accession 0001209191-22-043510

CIK 0001595893other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 4:18 PM ET

Size

5.0 KB

Accession

0001209191-22-043510

Insider Transaction Report

Form 4
Period: 2022-07-27
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2022-07-27$74.94/sh1,183$88,65428,700 total
Footnotes (1)
  • [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021.

Issuer

Turning Point Therapeutics, Inc.

CIK 0001595893

Entity typeother

Related Parties

1
  • filerCIK 0001707648

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:18 PM ET
Size
5.0 KB